ARTICLE | Company News
Genzyme Molecular licenses p53 rights to Affymetrix
June 29, 2000 7:00 AM UTC
Genzyme Molecular Oncology (GZMO) granted AFFX an exclusive license to certain high density DNA array diagnostic and research rights related to the p53 tumor suppressor gene. The license will allow AF...